These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23296550)

  • 1. Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease.
    Gołembiowska K; Wardas J; Noworyta-Sokołowska K; Kamińska K; Górska A
    Neurotox Res; 2013 Jul; 24(1):29-40. PubMed ID: 23296550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPS-induced oxidative stress and inflammatory reaction in the rat striatum.
    Noworyta-Sokołowska K; Górska A; Gołembiowska K
    Pharmacol Rep; 2013; 65(4):863-9. PubMed ID: 24145080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
    Gołembiowska K; Dziubina A
    Neurotox Res; 2012 Feb; 21(2):222-30. PubMed ID: 21830163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
    Gołembiowska K; Dziubina A
    Neurotox Res; 2012 Aug; 22(2):150-7. PubMed ID: 22407500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
    Gołembiowska K; Dziubina A; Kowalska M; Kamińska K
    Pharmacol Rep; 2008; 60(3):319-30. PubMed ID: 18622056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.
    Kase H; Aoyama S; Ichimura M; Ikeda K; Ishii A; Kanda T; Koga K; Koike N; Kurokawa M; Kuwana Y; Mori A; Nakamura J; Nonaka H; Ochi M; Saki M; Shimada J; Shindou T; Shiozaki S; Suzuki F; Takeda M; Yanagawa K; Richardson PJ; Jenner P; Bedard P; Borrelli E; Hauser RA; Chase TN;
    Neurology; 2003 Dec; 61(11 Suppl 6):S97-100. PubMed ID: 14663020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A
    Nunes ACL; Carmo M; Behrenswerth A; Canas PM; Agostinho P; Cunha RA
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the adenosine A
    Prasad K; de Vries EFJ; van der Meiden E; Moraga-Amaro R; Vazquez-Matias DA; Barazzuol L; Dierckx RAJO; van Waarde A
    Neuropharmacology; 2024 Apr; 247():109862. PubMed ID: 38325770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum.
    Gołembiowska K; Dziubina A; Kowalska M; Kamińska K
    Neurotox Res; 2009 Feb; 15(2):155-66. PubMed ID: 19384578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure.
    Quarta D; Ferré S; Solinas M; You ZB; Hockemeyer J; Popoli P; Goldberg SR
    J Neurochem; 2004 Mar; 88(5):1151-8. PubMed ID: 15009670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum.
    Gołembiowska K; Dziubina A
    Brain Res; 2004 Feb; 998(2):208-17. PubMed ID: 14751592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
    Varty GB; Hodgson RA; Pond AJ; Grzelak ME; Parker EM; Hunter JC
    Psychopharmacology (Berl); 2008 Oct; 200(3):393-401. PubMed ID: 18594798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.
    Hsu CW; Wang CS; Chiu TH
    J Biomed Sci; 2010 Jan; 17(1):4. PubMed ID: 20074377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation.
    Tozzi A; de Iure A; Marsili V; Romano R; Tantucci M; Di Filippo M; Costa C; Napolitano F; Mercuri NB; Borsini F; Giampà C; Fusco FR; Picconi B; Usiello A; Calabresi P
    PLoS One; 2012; 7(6):e38312. PubMed ID: 22715379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
    Alfinito PD; Wang SP; Manzino L; Rijhsinghani S; Zeevalk GD; Sonsalla PK
    J Neurosci; 2003 Nov; 23(34):10982-7. PubMed ID: 14645494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
    Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
    Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.
    Garção P; Szabó EC; Wopereis S; Castro AA; Tomé ÂR; Prediger RD; Cunha RA; Agostinho P; Köfalvi A
    Br J Pharmacol; 2013 Aug; 169(7):1600-11. PubMed ID: 23638679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.
    Bové J; Serrats J; Mengod G; Cortés R; Tolosa E; Marin C
    Exp Brain Res; 2005 Sep; 165(3):362-74. PubMed ID: 15968457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.
    Salamone JD; Farrar AM; Font L; Patel V; Schlar DE; Nunes EJ; Collins LE; Sager TN
    Behav Brain Res; 2009 Jul; 201(1):216-22. PubMed ID: 19428636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.